Takeda Pharmaceutical Co Adr (TAK)

Sep 29, 2026

KROS Begins Dosing in Phase II Study With Rinvatercept in DMD - Zacks Investment Research

Sep 29, 2026

Sep 25, 2026

Enzyme Replacement Therapy Market to Grow to USD 27.90 Billion by 2035 at a CAGR of 8.59%SNS Insider - GlobeNewswire Inc.

Sep 25, 2026

Sep 23, 2026

HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2026 - GlobeNewswire Inc.

Sep 23, 2026

Sep 23, 2026

AI in Drug Discovery Market Poised for Rapid Growth Through 2035, Fueled by Faster R&D, Precision Medicine and Rising Biopharma Investment - GlobeNewswire Inc.

Sep 23, 2026

Sep 21, 2026

Psoriatic Arthritis Market Landscape: 6 Key Late-Stage Drugs Set to Drive Future Growth | DelveInsight - GlobeNewswire Inc.

Sep 21, 2026

Sep 09, 2026

Intravenous Immunoglobulin Market Size Worth USD 30.83 Billion by 2035, Growing at 7.49% CAGR – SNS Insider - GlobeNewswire Inc.

Sep 09, 2026

Sep 08, 2026

Monoclonal Antibodies Market to Grow at 11.01% CAGR, Reaching USD 791.28 Billion by 2035 – SNS Insider - GlobeNewswire Inc.

Sep 08, 2026

Sep 07, 2026

Drug Repurposing Market to Reach USD 50.91 Billion by 2035, Expanding at 3.93% CAGR | SNS Insider - GlobeNewswire Inc.

Sep 07, 2026

Aug 29, 2026

Takeda stock advances after U.S. FDA clears MIMRYLO cancer drug - AD HOC NEWS

Aug 29, 2026

Aug 28, 2026

Protagonist Therapeutics receives FDA approval for polycythemia vera drug - Investing.com

Aug 28, 2026

Aug 27, 2026

Teva Pharma Industries Ltd ADR (TEVA) Peer Comparison – Compare with Others - valueresearchonline.com

Aug 27, 2026

Aug 18, 2026

Takeda Pharmaceutical Co Ltd (ADR) (TAK) News, Articles, Events & Latest Updates - Stocktwits

Aug 18, 2026

Aug 14, 2026

Takeda (NYSE:TAK) Climbs Into Focus On Sleep Disorder Milestone - Kalkine Media

Aug 14, 2026

Aug 07, 2026

Takeda (TAK) Q1 2026 Earnings Call Transcript - theglobeandmail.com

Aug 07, 2026

Aug 05, 2026

US FDA approves Takeda’s sleep disorder pill By Reuters - Investing.com

Aug 05, 2026

Aug 01, 2026

Takeda Pharmaceutical (TAK) Slips 0.93% to $17.09 as Defensive Sector Shows Mixed ToneBlock Trade Flow - vinanet.vn

Aug 01, 2026

Jul 31, 2026

Corporate Lobbying Dashboard - Quiver Quantitative

Jul 31, 2026

Jul 30, 2026

Murata ADR Surges 15%, SoftBank Group Jumps 7% as Semiconductor, Tech Stocks See Short-Covering - finance.biggo.com

Jul 30, 2026

Jul 26, 2026

Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026 - GlobeNewswire Inc.

Jul 26, 2026

Jul 26, 2026

Takeda Pharmaceutical (TAK) Gains 2.5%; Approaches Key Resistance LevelBPI Bull Correction - vinanet.vn

Jul 26, 2026

Jul 23, 2026

Teva Pharmaceutical Industries Limited (TEVA) stock price, news, quote and history - Yahoo Finance UK

Jul 23, 2026

Jul 22, 2026

[Latest] Global Botulinum Toxin in Urology Market Size/Share Worth USD 1.98 Billion by 2035 at a 6.08% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.

Jul 22, 2026

Jul 17, 2026

TAK: Takeda Pharmaceutical Co Ltd (ADR) Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Jul 17, 2026

Jul 17, 2026

Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes - GlobeNewswire Inc.

Jul 17, 2026

Jul 15, 2026

Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider - GlobeNewswire Inc.

Jul 15, 2026

Jul 13, 2026

Form 144 Takeda Pharmaceutical Company Limited For: 13 July By Investing.com - Investing.com Canada

Jul 13, 2026

Jul 13, 2026

Takeda invests $30M to build Indonesian plasma ecosystem - grafa.com

Jul 13, 2026

Jul 13, 2026

Form 144 Takeda Pharmaceutical Company Limited For: 13 July By Investing.com - Investing.com Nigeria

Jul 13, 2026

Jul 08, 2026

6 High-Yield International Dividend Stocks Analysts Love - Forbes

Jul 08, 2026

Jul 05, 2026

ETFs Investing in Takeda Pharmaceutical Co. Ltd. Sponsored ADR Stocks - TradingView

Jul 05, 2026

Jul 02, 2026

TAKTakeda Pharmaceutical Co ADR Latest SEC Filings - Finviz

Jul 02, 2026

Jul 02, 2026

TAKTakeda Pharmaceutical Co ADR Options - Finviz

Jul 02, 2026

Jul 02, 2026

TAKTakeda Pharmaceutical Co ADR Options - Finviz

Jul 02, 2026

Jul 02, 2026

TAKTakeda Pharmaceutical Co ADR Latest SEC Filings - Finviz

Jul 02, 2026

Jul 01, 2026

TAKTakeda Pharmaceutical Co ADR Latest SEC Filings - Finviz

Jul 01, 2026

Jul 01, 2026

TAKTakeda Pharmaceutical Co ADR Latest SEC Filings - Finviz

Jul 01, 2026

Jul 01, 2026

TAKTakeda Pharmaceutical Co ADR Options - Finviz

Jul 01, 2026

Jul 01, 2026

TAKTakeda Pharmaceutical Co ADR Options - Finviz

Jul 01, 2026

Jul 01, 2026

TAKTakeda Pharmaceutical Co ADR Latest SEC Filings - Finviz

Jul 01, 2026

Jul 01, 2026

TAKTakeda Pharmaceutical Co ADR Options - Finviz

Jul 01, 2026

Jul 01, 2026

TAKTakeda Pharmaceutical Co ADR Options - Finviz

Jul 01, 2026

Jul 01, 2026

TAKTakeda Pharmaceutical Co ADR Latest SEC Filings - Finviz

Jul 01, 2026

Jul 01, 2026

TAKTakeda Pharmaceutical Co ADR Latest SEC Filings - Finviz

Jul 01, 2026

Jul 01, 2026

India Celiac Disease Treatment Market Size & Outlook, 2033 - Grand View Research

Jul 01, 2026

Jun 28, 2026

TAKTakeda Pharmaceutical Co ADR Latest SEC Filings - Finviz

Jun 28, 2026

Jun 28, 2026

0A87 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 28, 2026

Jun 27, 2026

TAK-755 from Takeda Pharmaceutical Co.enzyme replacement for a rare bleeding disorder - Ad-hoc-news.de

Jun 27, 2026

Jun 27, 2026

TKDA Forecast — Price Target — Prediction for 2027 - TradingView

Jun 27, 2026

Jun 27, 2026

Takeda Pharmaceutical Co. Ltd. Sponsored ADR Actuals & Estimates (LS:A1CWZF) - TradingView

Jun 27, 2026

Jun 26, 2026

A1CWZF Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026